Τόμος 4 (1990) – Τεύχος 1 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 4 (1990) – Issue 1 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1. Institute of Organic and Pharmaceutical Chemistry, The National Hellenic Research Foundation, Athens, Greece

2. Laboratoire CPOP, Sciences II, Universite de Geneve

Accepted for publication: January 15, 1990

pharmakonpress[at]pharmakonpress[.]gr

2.       Szoka, F., Papahadjopoulos, D.: Liposomes: Preparation and characterisation. In: Liposomes: From Physical Structure to Therapeutic Applications (Knight, ed.), p. 51, Elsevier. North Holland Biomedical Press, 1981

3.       Lichtenberg, D., Barenholz, Y.: Liposomes: Preparation characterization and preservation. In: Methods of Biochemical Analysis (D. Glick, ed.). Vol. 33, John Wiley and Sons, New York, 1988

4.       Shinitsky, M., Barenholz, Y.: Dynamics of the hydrocarbon layer in liposomes of lecithin and sphingomyelin: containing dicetylphosphatë. J. Biol. Chem. 249: 2652 (1974)

5.       Woolley, P., Erbl, H.: Synthesis of enantiomerically pure phospholipids including phosphatidylserine and phosphatidylglycerol. Chem. Phys. Lipids 47: 55 (1988)

6.       Cohen, R., Barenholz, Y., Gatt, S., Dagan, A.: Preparation and characterization of well defined D-erythro sphingomyelins. Chem. Phys. Lipids 35: 371 (1984)

7.       Bruzik, K.S.: Synthesis and spectral properties of chemically and stereochemically homogeneous sphingomyelin and its analoges. J. Chem. Soc. Perkin Trans. I: 423 (1988)

8.       Puisieux, F., Delattre, J.: In: Les Liposomes: Applications Thérapeutiques. Technique et Documentation, Lavoisier, 1985

9.       Ramsamy, L.S., Brockerhoff, H.: Lyso phosphatidyl-choline-cholesterol complex. J. Biol. Chem. 257: 3570 (1982)

10.     Gregoriadis, G.: Drug entrapment in liposomes. FEBS Lett. 36: 292 (1973)

11.      Ryman, B.E., Tyrell, D.A.: Liposomes, bags of potential. Essays Bioch. 16: 49 (1980)

12.     Raab, W.: Les liposomes: Nouveau support de principes actifs en dermatologie. J. Suisse Pharm. 21: 533 (1989)

13.     Poste, G., Papahadjopoulos, D.: Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells. Proc. Natl. Acad. Sci. USA 73: 1603 (1976)

14.     Batzri. S., Korn, E.D.: Interaction of phospholipid vesicles with cells. Endocytosis and fusion as alternate mechanisms for the uptake of lipid-soluble and water soluble molecules. J. Cell Biol. 66: 621 (1975)

15.     Pagano, R.E., Huang. L: Interaction of phospholipid vesicles with cultured mammalian cells. J. Cell Biol. 67: 49 (1975)

16.     Dimitriadis, G.J.: Cellular uptake of ribonucleic acids entraped into liposomes. Cell Biology Int. Rep. 3: 543 (1979)

17.     Pagano, R.E., Schroitt, A.J., Struck, D.K.: Interactions of phospholipid vesicles with mamalian cells in vitro: Studies of mechanism. In: Liposomes: From Physical Structure to Therapeutic Applications (C.G. Knight, ed.), p. 323, Elsevier, North Holland, Amsterdam, 1981

18.     Scherphof, G.L., Damen, J., Wilschut, J.: Interactions of liposomes with plasma proteins. In: Liposome Technology (G. Gregoriadis, ed.), Vol. 3, p. 205, CRC Press Boca Raton, Florida, 1984

19.     Heath, T.D.: Interaction of liposomes with cells. Methods Enzymol. 149: 135 (1987)

20.    Kibat, P., Strieker, H.: Factoren der Elimination von in Liposomen verkapselten Arzneimodellsubstanzen nach intravenöser Gabe. Arzneimittelforschung 38: 1472 (1988)

21.     Patel, K.R., Li, M.P., Schuch, J.R., Baldeschwieler, J.E.: Modification of vesicle surfaces with amphiphilic sterols. Effect on permeability and in vivo tissue distribution. Biochim. Biophys. Acta 814: 256 (1985)

22.     Hertz, R., Barenholz, Y.: Permeability and integrity properties of lecithin-sphingomyelin liposomes. Chem. Phys. Lipids 15: 138 (1975)

23.     Gregoriadis, G., Ryman, B.E.: Fate of protein-containing liposomes injected into rats: An approach to the treatment of storage diseases. Bur. J. Biochem. 24: 485 (1972)

24.     Patel, H.M., Ryman, B.E.: Systemic and oral administration of liposomes. In: Liposomes: From Physical Structure to Therapeutic Applications (C.G. Knight, ed.), p. 410, Elsevier, North Holland, Amsterdam, 1981

25.     Dragsten, P.R., Mitchell, D.B., Corert, G., Baker, T.: Drug delivery using vesicles targeted to the hepatic asialoglycoprotein receptor. Biochim. Biophys. Acta 814: 256 (1985)

26.     Khokhar, A.R., Wright, Κ., Siddik, Z.H., Perez-Soler, R.: Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diamino-cyclohexane platinum (II) administered intravenously and into the proper hepatic artery. Cancer Chemother. Pharmacol. 22: 223 (1988)

27.     Parson, J.A., Rafferty, B., Stevenson, R.W., Zanelli, J.M.: Evidence that protease inhibitors reduce the degradation of parathyroid hormone and calcitonin injected subcutaneously. Br. J. Pharmacol. 66: 25 (1979)

28.    Stevenson, R.W., Patel, H.M., Parsons, J.A., Ryman, B.G.: Diabetologia 19: 317 (1980)

29.     Hirnle, P., Harzmann, R., Wright, J.K.: Patent blue V encapsulation in liposomes: potential applicability to endolymphatic therapy and preparative chromolymphography. Lymphology 21 (3): 187 (1988)

30.    Chaicumpa, W., Parairo, J.: Liposomes and their potential in oral cholera vaccines. Asian Pac. J. Allergy Immunol. 6 (2): 70 (1988)

31.     Baillet, F., Housset, M., Michelson, A.M., Paget, Κ.: Treatment of radiofibrosts with liposomal superoxide dismutase. Preliminary results of 50 cases. Free Radic. Res. Commun. 1 (6): 387 (1986)

32.     Rahman, Y.E., Cenry, E.A., Tollaksen, S.L., Wright, B.J., Nance, S.L., Thompson, J.F.: Liposome-encapsulated actinomycin D: Potential in cancer chemotherapy. Proc. Soc. Exp. Biol. Med. 146: 1173 (1974)

33.     Rustum, Y.M., Dave, C., Mayhew, D.C., Papahadjopoulos, D.: Role of liposome type and route of administration in the antitumour activity of liposome entrapped Ι–β-D-arabinofuranosylcytosine against mouse L 1210 leukemia. Cancer Res. 39: 1390 (1979)

34.     Supersaxo, A., Rubas, W., Hartmann, H.R., Schott, H., Hengartner, H., Schwendener, R.A.: The antitumor effect of lipophilic derivatives of 5-fluoro-2-deoxyuridine incorporated into liposomes. J. Microencapsul. 5: 1 (1988)

35.     Lokshina, E.A., Abisher, Bkh., Sagindykova, S.E., Ai- darkhanov, B.B.: Effect of alpha- and gamma-tocopherols on the cytochrome P-450 system in the liver of rats with E-aritaminosis. Effectiveness of liposomal forms of gramma-tocopherol. Biokhimiia 53: 1188 (1988)

36.     Patel, H.M., Ryman, B.E.: Oral administration of linsulin by encapsulation within liposomes. FEBS Lett. 62: 60 (1976)

37.     Fildes, F.J.T.: Liposomes: The industrial viewpoint. In: Liposomes. From Physical Structure to Therapeutic Applications (C.G. Knight, ed.), p. 465, Elsevier, North Holland, Amsterdam, 1981

38.    Gesztes, A., Mezei. M.: Topical anesthesia of the skin by liposome-encapsulated tetracaine. Anesth. Analg. 67: 1079 (1988)

39.     Taniguchi, K., Yamamoto, Y., Hakura, K., Miichi, H., Hayashi, S.: Assessment of ocular irritability of liposome preparations. J. Pharmacobiodyn. 11 (9): 607 (1988)

40.    Simmons, S.T., Sherwood, M.B., Nichols, D.A., Penne, R.B., Sery, T., Spaeth, G.L.: Pharmacokinetics of a 5- fluorouracil liposomal delivery system. Br. J. Ophtalmol. 72 (9): 688 (1988)

41.     Bonanomi, M.H., Velvart, M„ Weder, H.G.: Fate of different kinds of liposomes containing dexamethasone palmitate after intra-articular injection into rabbit joints. J. Microencapsul. 4 (3): 189 (1987)

42.     Metje, S., Brunke, R.A.: Hertstellung und Vermessung von Liposomen. Seifen Oel. Fette Wachse 114 (7): 234 (1988)

43.     Kirsh, R., Poste, G.: Liposome encapsulation of biological response modifiers: activation of tumoricidal macrophages. In: Liposome Technology (C. Gregoriadis, ed.), Vol. II, p. 32. 1984

44.     Kirsh, R., Bugelski, P.J., Poste, G.: Drug delivery to macrophages for the therapy of cancer and infectious diseases. Ann. N Y. Acad Scf. 507: 141 (1987)

45.     Kirsh, R., Poste, G.: Liposome-mediated macrophage activities. Methods Enzymol. 149: 147 (1987)

46.     M.A. Chirigos, M. Mitchell, M.H. Mastrangelo, M. Krim (eds): Modulation of Cellular Immunity in Cancer by Immune Modifiers. Raven Press, New York, 1981

47.     Poste, G., Kirsh, R., Fogler, W.E., Fidler, I.J.: Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes. Cancer Res. 39: 881 (1979)

48.    Coune, A.r Sculier, J.P., Meunier, F., Brassinne, C., Laduron, C., Hollaert, C.: Liposomes et infections. Potentialités thérapeutiques et données cliniques actuelles. Rev. Med. Liège 43 (18): 577 (1988)

49.     Bakker-Woudenberg, I.A.J.M., Lokerse, A.M., Vink Van Den Berg, J.C., Roerding, F.H., Michel, M.F.: Effect of liposome entrapped ampicillin on survival of listera monocytogenes in murine peritoneal macrophages. Antimicrob. Agents Chemother. 30: 295 (1986)

50.     Kende, M., Alving, C.R., Rill, W.L., Swartz, Jr. G.M., Canonico, P.G.: Enhanced efficacy of liposome encapsulated ribavirin against Rift valley fever virus infection in mice. Antimicrob. Agents Chemother. 27: 903 (1985).

51.     Lopez-Berestein, G., Fainstern, V., Hopfer, R„ Metha, K., Sullivan, M.P., Keating, M., Rosenblum, M.G., Metha, R„ Luna, M., Hersh, E.M., Reuben, J., juliano, R.L., Bodey, G.P.: Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J. Infect. Dis. 151: 704 (1985)

52.     MacLeod, D.L, Prescott, J.F.: The use of liposomally-entrapped gentamicin in the treatment of bovine Staphylococcus aureus mastitis. Can. J. Vet. Res. 52 (4): 445 (1988)

53.     Duzgunecs, N., Perumal, V.K., Kesavalu, L., Goldstein, J.A., Debs, R.J., Gangadharam, P.R.: Enhanced effect of liposome-encapsulated amikacin on Mycobacterium arium-M intracellular complex infection in beige mice. Antimicrob. Agents Chemother. 32: 1404 (1988)

54.     Grigorian, S.S., Simonov, A.N., Ivanova, A.M., Ershor, F.I.: Antiviral activity of amikasin incorporated into liposomes. Vopr. Virusol. 33 (3): 302 (1988)

55.     Bakker-Woudenberg, I.A., Lokerse, A.F., Roerdink, F.H.: Effect of lipid composition on activity of liposome- entrapped ampicillin against intracellular Listeria monocytogenes. Antimicrob. Agents Chemother. 32 (10): 1560 (1988)

56.     Yatvin, M.B., Tegmo-Larsson, I.M., Dennis, W.H.: Temperature and pH-sensitive liposomes for drug targeting. Methods Enzymol. 149: 77 (1987)

57.     Papahadjopoulos, D., Fraley, R., Heath, T.: In: Liposomes and Immunobiology (B.H. Tom, H.R. Six, ed.), Elsevier, North Holland, Amsterdam, 1980

58.     Weckernmann, H.P., Matzku, S., Strieker, H.: Optimisation of the covalent binding of monoclonal antibodies to liposomes. Arzneimittelforschung 38 (11): 1556 (1988)

59.     Thompson, W.S., Gross, R.H.: Antibodies introduced into living cells with liposomes localize specifically and inhib specific intracellular processes. Gen. Anal. Tech. 5 (4): 73 (1988)

60.    Heath, T.D.: Covalent attachment of proteins to liposomes. Methods Enzymol. 149: 111 (1987)

61.     Huang, L, Connor, J., Wang, C.Y.: pH-sensitive immunoliposomes. Methods Enzymol. 149: 88 (1987)

62.     Ashwell, G., Morell, A.G.: The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteines. Adv. Enzym. 41: 99 (1974)

63.     Shen, T.Y.: Saccharide determinants in selective drug delivery. Ann. N.Y. Acad. Sci. 507: 272 (1987)

64.     Das, N., Bachhawat, B.K., Mahato, S.B., Basu, M.K.: Plant glycosides in a liposomal drug delivery system. Biochem. J. 247 (2): 359 (1987)

65.     Moellerfeld, J.W., Prass, H., Ringsdorf, H., Hamazaki, H., Sunamoto, J.: Improved stability of black lipid membranes by coating with polysaccharide derivatives bearing hydrophobic anchor groups. Biochim. Biophys. Acta 857: 265 (1986)

66.     Demopoulos, C.A., Pinokard, R.N., Hanahan, D.J.: Platelet activating factor. Evidence for 1-O-alkylcetyl-sn- glyceryl-3-phosporylcholine as the active component (a new class of lipid mediators). J. Biol. Chem. 254: 9355 (1979)

67.     Skrika, E., Vakirtzi-Lemontas, C.: Platelet activating factor, a potent mediator of allergy, as a structural component of phospatidylcholine vesicles. In: Targeting of drugs. Anatomical and Physiological Considerations (C. Gregoriadis, G. Poste, eds), NATO AS 1 Series, Vol. 155, p. 121, 1988

68.    Vakirzi-Lemonias, C.: Hydrolysis of 1-0-alcyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AGEPC) by mouse serum. Biochem. Soc. Trans. 19: 689 (1984)

69.     Hwang, S.B., Lee, C., Cheah, M.J., Shen, T.Y.: Specific receptor sites for’ 1-0-alkyl-2-0-acetyl-sn-glycerol-3- phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. Biochemistry 22: 4756 (1983)

70.     Benveniste, J., Vargaftig, B.: Platelet-activating factor: An ether lipid with biological activity. In: Ether Lipids. Biochemical and Biomedical Aspects (H.K. Mangold, F. Paltauf, eds), p. 356, 1983

71.     Zimmermann, U., Pilwat, G.: Naturforsch 31: 732 (1976)

72.     Gupta, P.K., Hung, C.T.: Magnetically controlled targeted microcarrier systems. Life Set. 44 (3): 175 (1989)

73.     Kiwada, H., Sato, J., Yamada, S., Kato, Y.: Feasibility of magnetic liposomes as a targeting device for drugs. Chem.Pharm. Bull. 34: 4253 (1986)

74.     Kaye, S.B.: Liposomes-problems and promise as selective drug carriers. Cancer Treat. Rev. 8: 27 (1981)

75.     Poste, G., Kirsh, R., Kostler, T.R.: The challenge of liposome targeting in vivo. In: Liposome Technology (G. Gregoriadis, ed.), Vol. 3, p. 1, CRC Press, Boca Raton, Florida, 1984

76.     Reszka, R., Fichtner, I., Nissen, E., Arndt, D., Ladhoff, A.M.: Preparation, characterization, therapeutic efficacy and toxicity of liposomes, containing the antitumour drug cis-dicholorodiamineplatinum (II). J, Microencapsul. 4 (3): 201 (1987)

77.     Kaledin, VI., Popova, N.A., Nikolin, V.P., Semenova, L.A., Budker, B.G.: Decrease in the antimetastatic effect of vinblastine administered in liposomes. Eksp. Onkol. 10 (5): 43 (1988)

78.     Steerenherg, P.A., Storm, G., de Groot, G., Claessen, A., Bergers, J.J., Franken, M.A., van Hoesel, Q.G., Wubs, K.L., de Jong, W.H.: Liposomes as drug carrier system for cis-diamine-dichloroplatinum (II). Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution. Cancer Chemother. Pharmacol. 21 (4): 299 (1988)

79.     Storm, G.: Liposomes as delivery system for doxorubicin in cancer chemotherapy. Pharm. Weekl. (Sci.) 10 (6): 288 (1988)

80.    Gabizon, A., Goren, D., Barenholz, Y.: Investigations on the antitumor efficacy of liposome-associated doxorubicin in murine tumor models. Isr. J. Med. Sci. 24 (9-10): 512 (1988)

81.     Salord, J., Schuber, F.: In vitro drug delivery mediated by ecto-NAD+-glycohydrolase ligand targeted liposomes. Biochim. Biophys. Acta 971: 197 (1988)

82.    Dimitriadis, G.J.: Entrapment of ribonucleic acids in liposomes. FEES Letters 86: 289 (1978)

83.    Dimitriadis, G.J.: Entrapment of plasmid DNA in liposomes. Nucl. Acids Res. 6: 2697 (1979)

84.    Dimitriadis, G.J.: Liposomes as drug carriers. Epitheor. Klin. Farmakol. Farmakokinet., El. Ekd. 1: 125 (1983)

85.     Koufaki, M.i Plessas, C.T.: Human insulin: Chemistry, biosynthesis and production. Epitheor. Klin. Farmakol. Farmakokinet., EL Ekd. 7: 156 (1989)

86.    Nicolau, C., LePape, A., Sorcano, P., Fargette, F., Juhel, M.F.: In vivo expression of rat insulin following after intravenous administration of liposome-entraped gene for rat insulin. Proc. Natl. Acad. Sci. USA 80: 785 (1983)

87.     Nicolau, C., Leg rand, A., Grosse, E.: Liposomes as carriers for in vivo gene transfer and expression. Methods Enzymot. 149: 157 (1987)

88.    Buccholzer, F.J.: Thèse No 2341, Université de Genève, 1989

89.    Ehman, R.L., Brasch, R.C.: invest. Radiol. 21: 125 (1986)

90.    Chan, H.C., Magin, R.L, Swartz, H.M.: Delivery of nitroxide spin label to cultured cells by liposomes. Magn. Reson. Med. 8: 160 (1988)

91.     Devoiselle, J.M., Vion-Dury, J., Galons, J.P., Confort- Gouny, S., Coustaut, D., Canioni, P., Cozzone, P.J.: Entrapment of gadolinium – DTPA in liposomes. Characterization of vesicles by P-31 NMR spectroscopy. Invest. Radiol. 23: 719 (1988)

92.     Musu, C., Felder, E., Lamy, B., Schneider, M.: A liposomal contrast agent. Preliminary communication. Invest. Radiol. 23 (Suppl. 1): 126 (1988)

93.     Seltzer, S.E.: Contrast carrying liposomes. Current status. Invest. Radiol. 23 (Suppl. 1): 122 (1988)

94.     Gaber, B.P., Yager, P., Sheridan, J.P., Chang, E.L.: Encapsulation of hemoglobin in phospholipid vesicles. FEBS Lett. 153: 285 (1983)

95.     Farmer, M.C., Gaber, B.P.: Liposome-encapsulated hemoglobin as an artificial oxygen-carrying system. Methods Enzymol. 149: 184 (1987)

96.     Davis, S.S., Hunneyball, I.M., Ilium, L, Ratcliffe, J.H., Smith, A., Wilson, C.G.: Recent advances in the use of microspheres for targeted therapy. Drugs Exp. Clin. Res. 11 (9): 633 (1985)

97.     Otomo, S., Mizushima, Y., Aihara, H., Yokoyama. K., Watanabe, M., Yanagawa, A.: Prostaglandin E, incorporated in lipid microsplieres (lipo PGE 1). Drugs Exp. Clin. Res. 11 (9): 627 (1985)

98.    Yokoyama, K., Okamoto, H., Watanabe, M., Suyama, I., Mirushima, Y.: Development of a corticosteroid incorporated in lipid microspheres (liposteroid). Drugs Exp. Clin. Res. 11 (9): 611 (1985)

99.     Mizushima, Y.: Lipid microspheres as novel drug carriers. Drugs Exp. Clin. Res. 11 (9): 595 (1985)

100.  Davis, S.S., Walker, I.M.: Multiple emulsions as tar- getable delivery systems. Methods Enzymol. 149: 51 (1987)

101.   Fuhrhop, J.H., Mathieu, J.: Routes to functional vesicle membranes without proteins. Angew. Chem. Int. Ed. 23: 100 (1984)

102.   Baillie, A.J., Florence, A.I., Hume, L.R., Muirhead, G.T., Reogerson, A.: The preparation and properties of niosomes non-ionic surfactant vesicles. J. Pharm. Pharmacol. 37: 863 (1985)

103.   Poste, G.: Liposome targeting in vivo. Problems and opportunities. Biol. Cell. 47: 19 (1983)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr